News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1FOMC Preview: Warsh's First Show — Can Risk On Continue?【Buy US Spot Stocks, Get NVIDIA Free】2Hormuz Strait Reopens: Will the Federal Reserve Pivot Dovishly and Will the Market Reprice Rate Cuts?3US Stock Market Financing Hits Historical Limit! Morgan Stanley Warns: A Deleveraging Storm is Brewing

Bitcoin Price Rejects $43.5K, Why BTC Could Tumble In Short-Term
Newsbtc-btc·2023/12/28 11:28

Why Ripple Transferred 310 Million XRP Out of Escrow
BeInCrypto·2023/12/28 10:21

Bitcoin Stopped Ahead of $44K, BSV Explodes 60% (Market Watch)
BNB has finally caught to the recent altcoin rally, having surged by 12% and tapping $330.
Cryptopotato·2023/12/28 10:07

Cardano’s Valentine’s Upgrade to Bring More Cross-Chain Love
DailyCoin·2023/12/28 09:43

Chainlink (LINK) Bulls in Control as Price Hits Yearly High – $20 on the Horizon?
BeInCrypto·2023/12/28 09:05

Artificial Intelligence Tops Crypto Narratives in 2023 as AI Tokens Explode
BeInCrypto·2023/12/28 08:58

Nifty News: Trump cashing out NFT earnings
Cointelegraph·2023/12/28 06:22

Experts Confirm Bitcoin ETFs Will Actually Be BTC Backed
BeInCrypto·2023/12/28 05:51

Capital Fund Poised to Invest Billions in the Web3 Industry
BeInCrypto·2023/12/28 03:01

Top 10 Layer 2 Tokens Primed for a 2024 Breakout: Scaling Up the Future of Crypto
Coinedition·2023/12/28 02:25
Flash
20:48
According to a filing submitted to the U.S. Securities and Exchange Commission, biotechnology company Arvinas Holding Company LLC, pharmaceutical giant Pfizer, and Rigel Pharmaceuticals obtained approval under the Hart–Scott–Rodino Antitrust Improvements Act on June 11, 2026.This key development has removed regulatory obstacles for all parties to advance the previously announced licensing agreement. The conclusion of this agreement marks a new substantive phase in the related cooperation. Passing the HSR antitrust review is a crucial step in strategic collaborations involving intellectual property and market access. This usually means that regulatory authorities have determined the transaction will not materially harm competition in the relevant market. With this regulatory threshold crossed, all parties are expected to accelerate implementation of the detailed terms of the licensing agreement, boosting progress in related R&D or commercialization projects. This dynamic is being closely watched by industry observers.
20:48
According to documents submitted to the U.S. Securities and Exchange Commission, Trinity Industries Inc has successfully signed a credit agreement, obtaining an unsecured revolving credit line of up to $600 million.This agreement provides the company with significant financial flexibility to meet its working capital requirements, general corporate purposes, and other strategic objectives.
20:28
The Nasdaq Golden Dragon China Index closed down 2.50%, at 6,192.86 points, falling below the April 8, 2025 closing level of 6,198.18 points and approaching the September 23, 2024 closing level of 5,917.72 points.Among popular Chinese concept stocks, ASE Semiconductor fell by 4.5%, Pony.ai and XPeng dropped by more than 4%.
Trending news
MoreAccording to a filing submitted to the U.S. Securities and Exchange Commission, biotechnology company Arvinas Holding Company LLC, pharmaceutical giant Pfizer, and Rigel Pharmaceuticals obtained approval under the Hart–Scott–Rodino Antitrust Improvements Act on June 11, 2026.
According to documents submitted to the U.S. Securities and Exchange Commission, Trinity Industries Inc has successfully signed a credit agreement, obtaining an unsecured revolving credit line of up to $600 million.
News
